The microbiome testing kit market size has grown exponentially in recent years. It will grow from $1.63 billion in 2025 to $2.03 billion in 2026 at a compound annual growth rate (CAGR) of 24.3%. The growth in the historic period can be attributed to advancements in microbiome research, consumer wellness trends, DNA sequencing accessibility, digestive health awareness, research funding growth.
The microbiome testing kit market size is expected to see exponential growth in the next few years. It will grow to $4.8 billion in 2030 at a compound annual growth rate (CAGR) of 24%. The growth in the forecast period can be attributed to precision nutrition demand, AI-driven microbiome analytics, chronic disease prevention focus, e-commerce health platforms, personalized healthcare models. Major trends in the forecast period include growth of at-home diagnostic testing, personalized nutrition and wellness insights, expansion of gut health applications, preventive health screening adoption, increased consumer health awareness.
The rising demand for personalized medicine is anticipated to drive growth in the microbiome testing kit market in the coming years. Personalized medicine customizes treatment and prevention strategies based on an individual’s unique genetic profile, lifestyle, and environment. This approach has gained traction largely due to advancements in genomics, which allow for the accurate identification of genetic differences and individualized treatments. Microbiome testing kits support personalized medicine by delivering detailed insights into a person’s microbial makeup, making them valuable for tailored health management. These kits reduce uncertainty in dietary and lifestyle adjustments by offering precise, data-driven advice that enhances overall health and helps prevent diseases. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US nonprofit, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, compared to 12 in 2022. This growing demand for personalized medicine is thus contributing to the expansion of the microbiome testing kit market.
Leading companies in the microbiome testing kit industry are developing innovative products such as next-generation sequencing-based gut microbiome analysis to deliver personalized gut health insights and dietary recommendations. This technique rapidly decodes the DNA of all gut microbes to determine their types, abundance, and possible effects on health. For instance, in January 2025, CJ Bioscience Inc., a biotechnology firm from South Korea, introduced SMILE GUT, a direct-to-consumer gut microbiome test that provides personalized gut health information. The kit uses next-generation sequencing combined with artificial intelligence to analyze stool samples and produces a gut microbiome index score that measures microbial diversity, the balance between beneficial and harmful bacteria, and conformity with healthy gut profiles. It offers customized health advice, including probiotic and dietary recommendations, with results available within 14 business days, enabling users to better manage their gut health.
In January 2025, Pooch and Mutt Ltd., a pet food and treat company based in the UK, acquired Biome9 for an undisclosed sum. This acquisition allows Pooch and Mutt to enhance its science-driven pet nutrition products by delivering personalized, microbiome-based gut health solutions for dogs. Biome9 Limited, also UK-based, provides a microbiome testing kit designed specifically for dogs called the gutdiscovery test.
Major companies operating in the microbiome testing kit market are OraSure Technologies Inc., Genova Diagnostics Inc., Ombre Health Inc., Viome Inc., Zymo Research Corporation, EasyDNA Pty Ltd., Psomagen Inc., DayTwo Ltd., Atlas Biomed Group Limited., BIOHM Health Inc., Mapmygenome India Limited, Biomes NGS GmbH, Carbiotix AB, CosmosID Inc., Juno Bio Ltd., Microba Life Sciences Limited., Sun Genomics Inc., Unseen Bio ApS, InnerBuddies, MyMicroZoo B.V.
North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microbiome testing kit market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microbiome testing kit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the microbiome testing kit market by increasing costs of sequencing reagents, testing consumables, and laboratory equipment sourced globally. Laboratory-based kits and Asia-Pacific and European regions face the greatest impact. On the positive side, tariffs are accelerating domestic kit manufacturing, supply chain localization, and innovation in affordable at-home testing solutions.
The microbiome testing kit market research report is one of a series of new reports that provides microbiome testing kit market statistics, including microbiome testing kit industry global market size, regional shares, competitors with a microbiome testing kit market share, detailed microbiome testing kit market segments, market trends and opportunities, and any further data you may need to thrive in the microbiome testing kit industry. This microbiome testing kit market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A microbiome testing kit is a diagnostic tool designed to analyze microbial communities, including bacteria, viruses, and fungi, in a specific environment such as the human gut, skin, or oral cavity. These kits provide insights into an individual’s microbiome composition, supporting assessments of health, nutrition, and potential disease risk factors.
The primary product types of microbiome testing kits are at-home testing kits and laboratory-based testing kits. At-home testing kits allow individuals to collect and analyze gut or other body microbiota samples from home, offering personalized insights into microbial composition, diversity, and overall health. They utilize various sample types, including stool, saliva, and skin, and are applied in areas such as gut health, skin health, nutrition and diet, disease risk assessment, and other applications. Distribution channels include online pharmacies, retail stores, and other outlets. Key end-users include individuals, hospitals and clinics, research and academic institutes, and related organizations.
The microbiome testing kit market consists of sales of respiratory microbiome kits, infant microbiome kits, environmental microbiome kits, sample preservation and transport kits, next-generation sequencing (NGS) panels, and data interpretation platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The microbiome testing kit market size is expected to see exponential growth in the next few years. It will grow to $4.8 billion in 2030 at a compound annual growth rate (CAGR) of 24%. The growth in the forecast period can be attributed to precision nutrition demand, AI-driven microbiome analytics, chronic disease prevention focus, e-commerce health platforms, personalized healthcare models. Major trends in the forecast period include growth of at-home diagnostic testing, personalized nutrition and wellness insights, expansion of gut health applications, preventive health screening adoption, increased consumer health awareness.
The rising demand for personalized medicine is anticipated to drive growth in the microbiome testing kit market in the coming years. Personalized medicine customizes treatment and prevention strategies based on an individual’s unique genetic profile, lifestyle, and environment. This approach has gained traction largely due to advancements in genomics, which allow for the accurate identification of genetic differences and individualized treatments. Microbiome testing kits support personalized medicine by delivering detailed insights into a person’s microbial makeup, making them valuable for tailored health management. These kits reduce uncertainty in dietary and lifestyle adjustments by offering precise, data-driven advice that enhances overall health and helps prevent diseases. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US nonprofit, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, compared to 12 in 2022. This growing demand for personalized medicine is thus contributing to the expansion of the microbiome testing kit market.
Leading companies in the microbiome testing kit industry are developing innovative products such as next-generation sequencing-based gut microbiome analysis to deliver personalized gut health insights and dietary recommendations. This technique rapidly decodes the DNA of all gut microbes to determine their types, abundance, and possible effects on health. For instance, in January 2025, CJ Bioscience Inc., a biotechnology firm from South Korea, introduced SMILE GUT, a direct-to-consumer gut microbiome test that provides personalized gut health information. The kit uses next-generation sequencing combined with artificial intelligence to analyze stool samples and produces a gut microbiome index score that measures microbial diversity, the balance between beneficial and harmful bacteria, and conformity with healthy gut profiles. It offers customized health advice, including probiotic and dietary recommendations, with results available within 14 business days, enabling users to better manage their gut health.
In January 2025, Pooch and Mutt Ltd., a pet food and treat company based in the UK, acquired Biome9 for an undisclosed sum. This acquisition allows Pooch and Mutt to enhance its science-driven pet nutrition products by delivering personalized, microbiome-based gut health solutions for dogs. Biome9 Limited, also UK-based, provides a microbiome testing kit designed specifically for dogs called the gutdiscovery test.
Major companies operating in the microbiome testing kit market are OraSure Technologies Inc., Genova Diagnostics Inc., Ombre Health Inc., Viome Inc., Zymo Research Corporation, EasyDNA Pty Ltd., Psomagen Inc., DayTwo Ltd., Atlas Biomed Group Limited., BIOHM Health Inc., Mapmygenome India Limited, Biomes NGS GmbH, Carbiotix AB, CosmosID Inc., Juno Bio Ltd., Microba Life Sciences Limited., Sun Genomics Inc., Unseen Bio ApS, InnerBuddies, MyMicroZoo B.V.
North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microbiome testing kit market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microbiome testing kit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the microbiome testing kit market by increasing costs of sequencing reagents, testing consumables, and laboratory equipment sourced globally. Laboratory-based kits and Asia-Pacific and European regions face the greatest impact. On the positive side, tariffs are accelerating domestic kit manufacturing, supply chain localization, and innovation in affordable at-home testing solutions.
The microbiome testing kit market research report is one of a series of new reports that provides microbiome testing kit market statistics, including microbiome testing kit industry global market size, regional shares, competitors with a microbiome testing kit market share, detailed microbiome testing kit market segments, market trends and opportunities, and any further data you may need to thrive in the microbiome testing kit industry. This microbiome testing kit market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A microbiome testing kit is a diagnostic tool designed to analyze microbial communities, including bacteria, viruses, and fungi, in a specific environment such as the human gut, skin, or oral cavity. These kits provide insights into an individual’s microbiome composition, supporting assessments of health, nutrition, and potential disease risk factors.
The primary product types of microbiome testing kits are at-home testing kits and laboratory-based testing kits. At-home testing kits allow individuals to collect and analyze gut or other body microbiota samples from home, offering personalized insights into microbial composition, diversity, and overall health. They utilize various sample types, including stool, saliva, and skin, and are applied in areas such as gut health, skin health, nutrition and diet, disease risk assessment, and other applications. Distribution channels include online pharmacies, retail stores, and other outlets. Key end-users include individuals, hospitals and clinics, research and academic institutes, and related organizations.
The microbiome testing kit market consists of sales of respiratory microbiome kits, infant microbiome kits, environmental microbiome kits, sample preservation and transport kits, next-generation sequencing (NGS) panels, and data interpretation platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Microbiome Testing Kit Market Characteristics
3. Microbiome Testing Kit Market Supply Chain Analysis
4. Global Microbiome Testing Kit Market Trends and Strategies
5. Microbiome Testing Kit Market Analysis of End Use Industries
7. Global Microbiome Testing Kit Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Microbiome Testing Kit Total Addressable Market (TAM) Analysis for the Market
9. Microbiome Testing Kit Market Segmentation
10. Microbiome Testing Kit Market Regional and Country Analysis
11. Asia-Pacific Microbiome Testing Kit Market
12. China Microbiome Testing Kit Market
13. India Microbiome Testing Kit Market
14. Japan Microbiome Testing Kit Market
15. Australia Microbiome Testing Kit Market
16. Indonesia Microbiome Testing Kit Market
17. South Korea Microbiome Testing Kit Market
18. Taiwan Microbiome Testing Kit Market
19. South East Asia Microbiome Testing Kit Market
20. Western Europe Microbiome Testing Kit Market
21. UK Microbiome Testing Kit Market
22. Germany Microbiome Testing Kit Market
23. France Microbiome Testing Kit Market
24. Italy Microbiome Testing Kit Market
25. Spain Microbiome Testing Kit Market
26. Eastern Europe Microbiome Testing Kit Market
27. Russia Microbiome Testing Kit Market
28. North America Microbiome Testing Kit Market
29. USA Microbiome Testing Kit Market
30. Canada Microbiome Testing Kit Market
31. South America Microbiome Testing Kit Market
32. Brazil Microbiome Testing Kit Market
33. Middle East Microbiome Testing Kit Market
34. Africa Microbiome Testing Kit Market
36. Microbiome Testing Kit Market Competitive Landscape and Company Profiles
37. Microbiome Testing Kit Market Other Major and Innovative Companies
40. Microbiome Testing Kit Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Microbiome Testing Kit Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses microbiome testing kit market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for microbiome testing kit? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microbiome testing kit market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: At-Home Testing; Laboratory-Based Testing2) By Sample Type: Stool; Saliva; Skin; Other Sample Types
3) By Application: Gut Health; Skin Health; Nutrition And Diet; Disease Risk Assessment; Other Applications
4) By Distribution Channel: Online; Pharmacies; Retail Stores; Other Distribution Channel
5) By End-User: Individuals; Hospitals And Clinics; Research And Academic Institutes; Other End-Users
Subsegments:
1) By At-Home Testing: Gut Health Analysis; Digestive Function Assessment; Personalized Nutrition Guidance; Probiotic Response Evaluation2) By Laboratory-Based Testing Kits: Microbial Diversity Profiling; Pathogen Detection; Metabolic Activity Analysis; Antibiotic Resistance Screening
Companies Mentioned: OraSure Technologies Inc.; Genova Diagnostics Inc.; Ombre Health Inc.; Viome Inc.; Zymo Research Corporation; EasyDNA Pty Ltd.; Psomagen Inc.; DayTwo Ltd.; Atlas Biomed Group Limited.; BIOHM Health Inc.; Mapmygenome India Limited; Biomes NGS GmbH; Carbiotix AB; CosmosID Inc.; Juno Bio Ltd.; Microba Life Sciences Limited.; Sun Genomics Inc.; Unseen Bio ApS; InnerBuddies; MyMicroZoo B.V.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Microbiome Testing Kit market report include:- OraSure Technologies Inc.
- Genova Diagnostics Inc.
- Ombre Health Inc.
- Viome Inc.
- Zymo Research Corporation
- EasyDNA Pty Ltd.
- Psomagen Inc.
- DayTwo Ltd.
- Atlas Biomed Group Limited.
- BIOHM Health Inc.
- Mapmygenome India Limited
- Biomes NGS GmbH
- Carbiotix AB
- CosmosID Inc.
- Juno Bio Ltd.
- Microba Life Sciences Limited.
- Sun Genomics Inc.
- Unseen Bio ApS
- InnerBuddies
- MyMicroZoo B.V.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.03 Billion |
| Forecasted Market Value ( USD | $ 4.8 Billion |
| Compound Annual Growth Rate | 24.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
